US2010021949A1PendingUtilityA1
Method for Detecting Transferase Enzymatic Activity
Est. expirySep 6, 2022(expired)· nominal 20-yr term from priority
C12Q 1/66C12Q 1/485
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and kits for detecting transferase activity in a sample by measuring ATP using a composition comprising an ATP-dependent bioluminescence-generating enzyme, a luminogenic molecule and one or more transferase quenching agents.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A kit for measuring transferase enzymatic activity comprising:
(a) a reconstitution buffer solution comprising one or more transferase quenching agents, wherein the transferase quenching agent selectively stops transferase activity without substantially affecting bioluminescent-generating enzyme activity; (b) a composition comprising a luminogenic molecule and a bioluminescence-generating enzyme; and (c) directions for using the kit.
28 . The kit of claim 27 wherein the transferase enzymatic activity comprises kinase activity or ion channel/pump activity.
29 . The kit of claim 28 wherein the transferase enzymatic activity comprises protein kinase activity, protein lipid-dependent kinase activity, polynucleotide kinase activity, or sugar kinase activity.
30 . The kit of claim 5 wherein the protein kinase comprises a Ser/Thr protein kinase, a protein tyrosine kinase, or a protein lipid-dependent kinase.
31 . The kit of claim 30 wherein the Ser/Thr protein kinase comprises cAMP-dependent protein kinase (PKA), calcium and phosphlipids dependent protein kinase (PKC), cGMP-dependent protein kinase (PKG), calcium and calmodulin dependent protein kinase (CaM KII) or a dual specificity protein kinase.
32 . The kit of claim 31 wherein the dual specificity protein kinase comprises mitogen activated protein kinase (MAPK) or mitogen activated protein kinase kinase (MEK).
33 . The kit of claim 30 wherein the tyrosine kinase comprises Rous sarcoma related protein kinases (Src), or Src family protein tyrosine kinases.
34 . The kit of claim 33 wherein the Src family protein tyrosine kinases comprise Src, Lck, Fyn, or Lyn.
35 . The kit of claim 33 wherein the growth factor receptors comprise epidermal growth factor receptor (EGFR), platelet derived growth factor receptor (PDGFR) or steel growth factor receptor (c-KIT).
36 . The kit of claim 30 wherein the lipid dependent protein kinases comprises Type I phosphoinositide 3-OH phosphotidylinositol kinase (PI3K).
37 . The kit of claim 26 wherein the transferase quenching agent comprises a detergent.
38 . The kit of claim 37 wherein the detergent comprises a cationic detergent, anionic detergent, or zwitterionic detergent.
39 . The kit of claim 38 wherein the cationic detergent comprises dodecyltrimethylammonium bromide, cetyltrimethylammonium bromide and benzyldimethyldodecylammonium bromide.
40 . The kit of claim 38 wherein the cationic detergent is dodecyltrimethylammonium bromide.
41 . The kit of claim 38 wherein the anionic detergent comprises SDS and deoxycholate.
42 . The kit of claim 38 wherein the zwitterionic detergent comprises sulfobetaine 3-10.
43 . The kit of claim 26 wherein the transferase quenching agent comprises a metal chelating agent.
44 . The kit of claim 43 wherein the transferase quenching agent comprises EDTA or EGTA.
45 . The kit of claim 26 wherein the transferase inhibitor comprises staurosporine, or a peptide or protein inhibitor.
46 . The kit of claim 26 wherein the luminogenic molecule comprises D-luciferin or a luciferin derivative and the bioluminescent enzyme comprises a luciferase.
47 . The kit of claim 46 wherein the luciferase comprises a thermostable luciferase.Join the waitlist — get patent alerts
Track US2010021949A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.